Aqueous/vitreous humour replacement medium

Intended purpose

AJL CELL 2% is indicated as adjuvant therapy in surgeries of the anterior segment of the eye, including cataract surgery. AJL CELL 2% maintains the depth of the anterior chamber during the procedure and allows for greater precision during surgery. This provides tissue protection, in turn, preventing the risk of trauma to the corneal endothelium and other eye tissues.